Instituto Português de Oncologia Francisco Gentil (IPO) / Portuguese Oncology Institute
Research facility
Location:
Lisboa / Lisbon, Coimbra, Porto,
Portugal (PT)
ISNI: 0000000406310608
ROR: https://ror.org/00r7b5b77
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group (2017)
Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, Hillengass J, et al.
Journal article, Review article
PLA2R-positive (primary) membranous nephropathy in a child with IPEX syndrome (2017)
Chuva T, Pfister F, Beringer O, Felgentreff K, Buettner-Herold M, Amann KU
Journal article
Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status (2016)
Luedeke M, Rinckleb AE, Fitzgerald LM, Geybels MS, Schleutker J, Eeles RA, Teixeira MR, et al.
Journal article
Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline (2015)
Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, Repici A, Vieth M, De Ceglie A, Amato A, et al.
Journal article, Review article
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1 (2015)
Cheng THT, Thompson D, Painter J, O'Mara T, Gorman M, Martin L, Palles C, et al.
Journal article
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk (2015)
Painter JN, O'Mara TA, Batra J, Cheng T, Lose FA, Dennis J, Michailidou K, et al.
Journal article